"The survey confirmed APM's primary challenge being an inability to correlate and extract value from vast volumes of data from an increasing number of specialized monitoring tools across silos and domains in real-time. Sometimes referred to as "APM-generated Big Data," this data must be transformed into practical information with a bearing on business activity, customer experience, applications, and infrastructure."
Lots of lower volume rinses on this stock which can be frustrating but almost always on less or lower volume....The big green accumulation bars are encouraging.
and of course there could be overallotment
Based on stock trading action after hours it looks like it will price 7 to 7.50
What a sad board this is to read which so much misleading information
btw why mention ROSG offering only and not many of the other stocks which were well supported once the offering overhead was removed--i.e. NSPH
Yahoo Finance is one source among many, and no I certainly do not rely on it. I check it against many other sources....
10,573,000 shares outstanding
Do you see it as an index addition? I am missing it on lists; it is on the Russell microcap list but I don't see it as an addition anywhere
Steve Anderson Miller Tabak--he has a 28 target
here is the cnbc segment
CKH CEO buys big for the second time in the last three months, bigger than Sept., he took 45.5k shares worth 3.9 million, upped his stake by over 45%
I like the insider buying in early october on this stock
It has been pulling back after a strong move off the lows on a volume decrease, this seems a good entry point
Amarin Corporation plc (Nasdaq:AMRN), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that Joseph Zakrzewski, Amarin's Executive Chairman and Chief Executive Officer, will present at the Wedbush Securities 2011 Life Sciences Management Access Conference to be held at Le Parker Meridien in New York City. The presentation will take place at 12:40pm ET on Aug. 17, 2011. A live webcast of the presentation will be available at the following URL:
from last summer
they specialize in short research
they called STRA short which was a good call; they liked CPRT short which was not at all a good call